THOUGHTSPOT 11 Essential Steps to Ensure Patient Safety in Healthcare FacilitiesByCarla AdamsAugust 8, 20240Comments
THOUGHTSPOT The Future of Personalized Medicine – How Pharma is Tailoring Treatments to IndividualsByCarla AdamsAugust 8, 20240Comments
News The US FDA Approves Citius Pharmaceuticals’ Lymphir to Treat R/R Cutaneous T-Cell Lymphoma (CTCL) ByDipanshu DixitAugust 8, 20240Comments
VIEWPOINTS TCOC Management in Oncology: Jennifer Fernandez from The Oncology Network in a Dialogue Exchange with PharmaShotsBySaurabh ChaubeyAugust 7, 20240Comments
News Takeda Reports the EC’s Approval of Adzynma to Treat Congenital Thrombotic Thrombocytopenic Purpura (cTTP) ByDipanshu DixitAugust 7, 20240Comments
THOUGHTSPOT How Innovative Public Relation Solutions Shape the Biopharma Industry?BySaurabh ChaubeyAugust 6, 20240Comments
News Servier Reports the US FDA’s Approval of Voranigo (Vorasidenib) to Treat Grade 2 IDH-Mutant Glioma ByDipanshu DixitAugust 6, 20240Comments
VIEWPOINTS Establishing Safe Treatment: Dr. Robert Rifikin from Rocky Mountain Cancer Centers in Conversation with PharmaShotsBySaurabh ChaubeyAugust 5, 20240Comments
